news_6

Asia-Pacific Industrial Internet-of-Things Market Report 2020: Industrial IoT Security Solutions Set to be Critical for Industrial IoT Deployments – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Emerging Disruptive Technologies Powering the Asia-Pacific Industrial Internet-of-Things Market, 2020" report has been added to ResearchAndMarkets.com's offering. The...

news_6

Japan Industrial Internet of Things (IIoT) in Cyber Security Market Report 2020: Opportunities in Mission Assurance, Appropriate Risk Management and Response to Cyber Threats & ‘New Cyber Hygiene’ – ResearchAndMarkets.com

news_6

Professor Juan Marchal Believes Propanc Biopharma’s Proenzyme Therapy May Offer New Treatment Opportunity for Cancer Patients

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients...

news_6

China Cosmetics Markets, Forecast & Opportunities, 2026: Focus on Skin care, Hair Care, Bath & Shower products, Makeup & Color Cosmetics, Fragrances & Deodorants – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Cosmetics Market By Type (Skin care, Hair Care, Bath & Shower products, Makeup & Color Cosmetics, Fragrances...

news_6

Celltrion Healthcare receives European Commission (EC) approval for the first high concentration, low-volume and citrate-free biosimilar adalimumab, YuflymaTM (CT-P17)

Yuflyma™ (CT-P17) is the first adalimumab biosimilar with a high concentration, low-volume and citrate-free formulation; 60% of adalimumab market captured...